Literature DB >> 12911730

Detection of cervical neoplasia using measurement of Brn-3a in cervical smears with persistent minor abnormality.

M Sindos1, D Ndisang, N Pisal, C Chow, A Deery, A Singer, D Latchman.   

Abstract

Measurement of the Brn-3a cellular transcription factor in cervical smears from women referred for colposcopy may improve the detection of underlying cervical neoplasia. In those women referred with persisting borderline or mildly dyskaryotic smears, those who had histologically proven underlying CIN II/III, had statistically significant higher Brn-3a levels than those with a similar smear but histologically shown to have HPV, CIN I, or no cervical abnormality. These results indicate that Brn-3a could play an important role in the near future in improving cervical cancer screening.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911730     DOI: 10.1046/j.1525-1438.2003.13303.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds.

Authors:  Daniel Ndisang; Felipe Lorenzato; Michael Sindos; Ashfaq Khan; Albert Singer; David S Latchman
Journal:  Obstet Gynecol Int       Date:  2010-03-09

2.  Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Authors:  Emmanouil Papasavvas; Andrew V Kossenkov; Livio Azzoni; Nicola M Zetola; Agnieszka Mackiewicz; Brian N Ross; Matthew Fair; Surya Vadrevu; Doreen Ramogola-Masire; Ian Sanne; Cynthia Firnhaber; Luis J Montaner
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.